SCHEMBL562485

SCHEMBL562485

CCCCCC=CCC=CCCCCCCCC(=O)Oc1cc(O)ccc1Sc1ccc(O)cc1O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 1/20 0.48
POLM Q9NP87 1/20 0.47
POLK Q9UBT6 1/20 0.47
POLL Q9UGP5 1/20 0.47
POLH Q9Y253 1/20 0.47
ALDH1A1 P00352 5/20 0.44
HPGD P15428 2/20 0.44
HTR2A P28223 1/20 0.44
GLA P06280 1/20 0.44
MAPT P10636 1/20 0.44
THRB P10828 1/20 0.44
PSMB11 A5LHX3 1/20 0.44
PSMA7 O14818 1/20 0.44
PSMB1 P20618 1/20 0.44
PSMA1 P25786 1/20 0.44
PSMA2 P25787 1/20 0.44
PSMA3 P25788 1/20 0.44
PSMA4 P25789 1/20 0.44
PSMB8 P28062 1/20 0.44
PSMB9 P28065 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL562484 1.00 ELANE (0.48) ELANEPOLMPOLKPOLLPOLH
SCHEMBL563157 0.91 HTT (0.48) POLMPOLKPOLLPOLHALDH1A1
SCHEMBL562525 0.91 HTT (0.48) POLMPOLKPOLLPOLHALDH1A1
SCHEMBL563127 0.91 HTT (0.48) POLMPOLKPOLLPOLHALDH1A1
SCHEMBL27912643 0.83 ELANE (0.52) ELANEPOLMPOLKPOLLPOLH
SCHEMBL28064157 0.81 ELANE (0.49) ELANEPOLMPOLKPOLLPOLH
SCHEMBL563129 0.81 HTT (0.49) ALDH1A1HPGDKDM4ELMNATDP1
SCHEMBL562207 0.81 ELANE (0.46) ELANEPOLMPOLKPOLLPOLH
SCHEMBL562208 0.81 ELANE (0.46) ELANEPOLMPOLKPOLLPOLH
SCHEMBL3948637 0.79 CNR2 (0.60) ELANEPOLMPOLKPOLLPOLH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8859819-B2 Sulphurated derivatives of resorcinol, preparation of same and cosmetic uses thereof PIERRE FABRE DERMO-COSMETIQUE (FR) 2014-10-14 US claimed
US-20120034176-A1 SULPHURATED DERIVATIVES OF RESORCINOL, PREPARATION OF SAME AND COSMETIC USES THEREOF PIERRE FABRE DERMO-COSMETIQUE (FR) 2012-02-09 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120034176-A1 SULPHURATED DERIVATIVES OF RESORCINOL, PREPARATION OF SAME AND COSMETIC USES THEREOF CBR3, ACSL3, MSRB3 ELANE 3333/4885POLM 2667/4885POLK 1916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.